ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HCID 3442作成日:2026年10月27日

フザリン酸

5-ブチルピコリン酸 · フサリニン酸 · 5-ブチルピリジン-2-カルボン酸 · 5-ブチル-2-ピリジンカルボン酸 · フサリン酸 · フサル酸 · フザリン酸 · Fusaric

https://huagongshe.com/ja/chemical/3442

フザリン酸 の分子構造式

識別子と物理属性

CAS No.536-69-6
分子式C10H13NO2
平均分子量179.22 g/mol
単同位体質量179.09462866 g/mol
SMILESCCCCc1ccc(C(=O)O)nc1
InChIKeyDGMPVYSXXIOGJY-UHFFFAOYSA-N
PubChem CID3442
ChEMBLCHEMBL24510
ChEBICHEBI:5199
EC No.208-643-0
DTXSIDDTXSID5023085
現地名フザリン酸

化学・物理的性質

XLogP2.6
極性表面積50.2
水素結合供与体数1
水素結合受容体数3
回転可能結合数4
重原子数13
形式電荷0
複雑度170
Color/FormCOLORLESS CRYSTALS
融点96-98 °C96-100 °C
沸点311.75°C (rough estimate)
密度1.1248 (rough estimate)
屈折率1.5710 (estimate)
貯蔵条件Inert atmosphere,Store in freezer, under -20°C
溶解度エタノール: 50 mg/mL、透明、微黄色
外観・状態結晶性粉末
pKa(酸解離定数)1.11±0.50(Predicted)
色オフホワイトからかすかな黄色
Merck14,4314
BRN125804
InChI1S/C10H13NO2/c1-2-3-4-8-5-6-9(10(12)13)11-7-8/h5-7H,2-4H2,1H3,(H,12,13)
InChIKeyDGMPVYSXXIOGJY-UHFFFAOYSA-N
SMILESCCCCc1ccc(nc1)C(O)=O
LogP(分配係数)1.960 (est)
CAS データベース536-69-6(CAS DataBase Reference)
EPAの化学物質情報2-Pyridinecarboxylic acid, 5-butyl- (536-69-6)

化学的特性

off-white to faint yellowish crystalline powder

安全性と法規制

GHS 分類WarningH302 (98.6%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 69 reports by companies from 2 notifications to the ECHA C&L Inventory.Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Special ReportsA REVIEW WITH 28 REFERENCES OF THE ROLE OF FUSARIC ACID AS A PLANT TOXIN.[KALYANASUNDARAM RMODE OF ACTION OF FUSARIC ACIDPLANT DIS PROBL PROC INT SYMP 1ST: 142 (1970)]
Hazard Classes and CategoriesAcute Tox. 4 (98.6%)
TreatmentNatamycin ophthalmic suspension is the drug of choice for filamentous fungal infections such as mycotic keratitis. (L1964)
相互作用WHEN FUSARIC ACID (100 MG/KG, IP) WAS ADMIN TO MALE MICE 6 HR AFTER ALCOHOL WITHDRAWAL, BRAIN NORADRENALINE, DOPAMINE, & SEROTONIN CONCN WERE 112.8, 186.4, & 652.8 NG/G 4 HR LATER. FUSARIC ACID ADMIN DECREASED BRAIN NORADRENALINE LEVEL ACCOMPANIED BY AN ENHANCED ALCOHOL WITHDRAWAL SYNDROME.
健康影響Fusaric acid can contribute to mycotic keratitis infections. It also has developmental and neurological effects. (A3021, A3023)
暴露経路Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)
毒性の概要Fusaric acid affects neurotransmitter levels by acting as a partial inhibitor on tyrosine-hydroxylase and an inhibitor on dopamine-beta-hydroxylase. This has been shown to cause elevated serotonin, 5-hydroxyindoleacetic acid, tyrosine, and dopamine levels in the brain, as well as decreased norepinephrine levels. These changes in neurotransmitter levels may be responsible for effects such as hypotension, altered behavior and locomotive activity, neurological disorders, and developmental problems. (A3020, A3021, A3022, A3023)
Signs and SymptomsFusaric acid can cause vomiting, hypotension, and alterations in behavioral and locomotive activity. (A3020, A3022, A3023)

用途

解説

5-butyl-2-pyridinecarboxylic acid.C10H13NO2(179.12).フザリン酸は,イネの馬鹿苗病菌Gibberella fujikuroiの代謝産物.無色の板状晶.融点108 ℃.イネ苗の無秩序な伸長を抑制する作用があり,またチフス菌に対して発育阻止作用がある.最近,ドーパミン-β-ヒドロキシラーゼの阻害作用があり,組織中のノルアドレナリンを減少させ,動物に顕著な血圧降下作用を示すとともに,ヒトの高血圧症の降圧剤として有効であることが見いだされた.森北出版「化学辞典(第2版)

使用

Fusaric acid may be used as a derivatizing reagent for the quantification of hydroxysteroids and dehydroepiandrosterone (DHEA)and sulfated DHEA in biological samples using liquid chromatography electrospray-ionization-tandem mass spectrometry (LC/ESI-MS/MS) technique.

一般的な説明

Fusaric acid is a novel proton-affinitive derivatizing agent, having an ionization moiety and a hydrophobic moiety. It is commonly used for the derivatization of alcohols and phenols, by liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS).

製法・合成法

純化方法

Dissolve it in CHCl3, dry (Na2SO4), filter, evaporate and recrystallise the residue from 50 parts of pet ether (b 40-60o), CHCl3/pet ether or EtOAc, then sublime it in vacuo. The amide crystallises from MeOH with m 128.2-129.0o. The copper salt forms bluish violet crystals from H2O and has m 258-259o. [Hardegger & Nikles Helv Chim Acta 39 505 1956, Schreiber & Adam Chem Ber 93 1848 1960, NMR and MS: Tschesche & Führer Chem Ber 111 3500 1978, Beilstein 22 III/IV 764, 22/2 V 384.]

Natural Pollution SourcesTHE TOXIN ISOLATED FROM THE CULTURE MEDIA OF FUSARIUM OXYSPORUM F VASINFECTUM WAS IDENTIFIED AS FUSARIC ACID.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Non-Human Toxicity ExcerptsDOPAMINE BETA-HYDROXYLASE INHIBITOR & HYPOTENSIVE ACTIVITY...IN THE MOUSE & RAT, A MAX DAILY DOSE OF 125 MG/KG ORALLY CAUSED NO DEFECTS BUT DELAY IN OSSIFICATION & GROWTH OF THE MOUSE FETUSES WAS FOUND. AT THE SAME DOSE, NO EFFECTS WERE FOUND IN THE RABBIT. /FUSARIC ACID-CA/FUSARIC ACID (10 MG/KG, IV) CAUSED A RAPID & DOSE-RELATED HYPOTENSION, TACHYCARDIA, TACHYPNEA, INCREASE IN BLOOD FLOW IN THE UPPER MESENTERIC ARTERY, & DECREASE IN BLOOD FLOW IN THE FEMORAL ARTERY IN DOGS. FUSARIC ACID (0.3-3 MG) HAD A DOSE-DEPENDENT NEGATIVE INOTROPIC & NODAL RHYTHM DECREASING ACTIVITY IN NODAL & PAPILLARY MUSCLE PREPARATIONS.THE EFFECTS OF FUSARIC ACID (FA), A DOPAMINE-BETA-HYDROXYLASE INHIBITOR, WERE DETERMINED ON AGGRESSION, MOTOR ACTIVITY, & BRAIN MONAMINES AT DOSES OF 3.2-60 MG/KG FOLLOWING ADMIN OF DIETARY SUPPLEMENTS OF L-TYROSINE OR BALANCED PROTEIN TO MALE ALBINO MICE. COMPARED TO SALINE-INJECTED CONTROL ANIMALS, BOTH AGGRESSION & MOTOR ACTIVITY WERE REDUCED BY THE HIGHEST DOSES OF FUSARIC ACID. TREATMENT WITH FA AT DOSES OF 30 TO 60 MG/KG DECREASED BRAIN NOREPINEPHRINE, DOPAMINE, & BRAIN TYROSINE IN ANIMALS FED THE TYROSINE SUPPLEMENT. IN CONTRAST, FA INCREASED 5-HYDROXYTRYPTAMINE & CAUSED MARKED INCREASES IN 5-HYDROXYINDOLEACETIC ACID AT THE HIGHEST DOSES.
F10
水環境危害等級(WGK)3
TSCA 収載状態TSCA listed
RTECS 番号US5625000
輸送番号(UN)2811
毒性LD50 orally in mice: 230 mg/kg (Ishii)
税関コード29333999
危険文句(R)22
危険表示Xn
安全措置(S)24/25
危険等級6.1(b)Acute Tox. 4 Oral
包装等級III
貯蔵分類11 - Combustible Solids
有害物質データ536-69-6(Hazardous Substances Data)